USPTO serial 97823129
AKAMIS BIO
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Nov 5, 2024
- Examiner
- JARAMILLO, JAVIER R
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with AKAMIS BIO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Abingdon, Oxfordshire, GB
Abingdon, Oxfordshire, GB
Abingdon, Oxfordshire, GB
CAMBRIDGE, MA, US
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Brian J. Focarino
Brian J. Focarino Cooley LLP1299 Pennsylvania Ave., NW, Suite 700Washington, DC 20004United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; biotechnological preparations for the medical treatment of solid tumors; biotechnological preparations for the treatment of oncological diseases and disorders | ACTIVE | — |
| 035 | Marketing services in the field of pharmaceutical products; product marketing services in the field of pharmaceutical products; market research in the field of pharmaceutical products; market forecasting in the field of pharmaceutical products; market evaluation services, namely, market analysis and research services in the field of pharmaceutical products; online retail and wholesale store services for pharmaceutical products; online retail and wholesale store services for pharmaceutical preparations; advisory, information and consultancy services relating to the aforementioned services | ACTIVE | — |
| 042 | Pharmaceutical research and development services; pharmaceutical drug development services; research and development of new pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research; biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medical research in the nature of genome organization and functional analysis; genetic testing for scientific research purposes; research and development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy and therapeutics; technological consulting services, namely, product development consultation relating to the manufacture of pharmaceuticals; technological consulting services, namely, product development consultation relating to the design of manufacturing methods for pharmaceuticals; advisory, information and consultancy services relating to the aforementioned services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Akamis Bio Limited
- Other trademarks owned by Akamis Bio Limited
- Other trademarks owned by Akamis Bio Limited
- Other trademarks owned by AKAMIS BIO, INC.
- Other trademarks in Class 005
- Other trademarks in Class 035
- Other trademarks in Class 042
- Similar marks named AKAMIS BIO
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 22, 2026 | ASGN | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | — |
| Feb 11, 2026 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 11, 2026 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 11, 2026 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Feb 11, 2026 | CHAN | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | — |
| Feb 11, 2026 | COAR | TEAS CHANGE OF OWNER ADDRESS RECEIVED | — |
| Nov 5, 2024 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Nov 5, 2024 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 20, 2024 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 20, 2024 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 31, 2024 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 17, 2024 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 17, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 17, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 17, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 17, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 16, 2024 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 16, 2024 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 16, 2024 | ALIE | ASSIGNED TO LIE | — |
| Jan 26, 2024 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 11, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 11, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 1, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 27, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Sep 27, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 27, 2023 | ECDR | TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS | — |
| Sep 27, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 25, 2023 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Mar 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 9, 2023 | NWAP | NEW APPLICATION ENTERED | — |